Bibliografisk noteFunding Information:
CP reported receiving speaking fees from Lundbeck Pharma A/S and research grants from the Danish Heart Foundation and the Eva and Henry Frænkel Memorial Foundation. GHG reported receiving research grants from Bristol-Myers Squibb, Pfizer, Boehringer Ingelheim, and Bayer. LK reported receiving lecture fees from Novartis and Bristol-Myers Squibb. CT-P reported receiving research grants from Bayer. EF reported receiving independent research grant from Janssen Pharmaceutical and BMS. KK reported receiving speaking fees from Novartis and research grants from the Laerdal Foundation. LBP, MPA, LØ, MDB, MS, and SH declare that they have no conflict of interest.
© 2021, The Author(s), under exclusive licence to Springer-Verlag GmbH, DE part of Springer Nature.
Copyright 2021 Elsevier B.V., All rights reserved.